Soleus Capital Management, L.P. Xilio Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.97 - $3.03 $446,636 - $686,958
-226,719 Reduced 49.98%
226,941 $610,000
Q2 2022

Aug 15, 2022
SELL
$2.08 - $7.2 $49,576 - $171,612
-23,835 Reduced 4.99%
453,660 $1.33 Million
Q4 2021

Feb 14, 2022
BUY
$9.69 - $25.11 $4.63 Million - $12 Million
477,495 New
477,495 $7.64 Million

Others Institutions Holding XLO

# of Institutions
34
Shares Held
14M
Call Options Held
0
Put Options Held
0
View Full List

About Xilio Therapeutics, Inc.

XLO Quotes by TradingView
  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $24.2M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email